Impact of Drug-Coated Balloon-Based Revascularization in Patients with Chronic Total Occlusions
Journal of Clinical Medicine · 09.06.2024 · 13 (12) · 3381
DOI: 10.3390/jcm13123381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.06.2024. Verfasst von Eun-Seok Shin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, Republic of Korea. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Percutaneous coronary intervention (PCI) with a drug-eluting stent (DES) for chronic total coronary occlusions (CTOs) improves clinical symptoms and quality of life. However, data on drug-coated balloon (DCB)-based PCI in CTO lesions are limited.
Methods
A total of 200 patients were successfully treated for CTO lesions, either with DCB alone or in combination with DES (DCB-based PCI). They were compared with 661 patients who underwent second-generation DES implantation for CTO from the PTRG-DES registry (DES-only PCI). The endpoint was major adverse cardiovascular events (MACEs), which included a composite of cardiac death, myocardial infarction, stent or target lesion thrombosis, target vessel revascularization, and major bleeding at 2 years.
Results
In the DCB-based PCI group, 49.0% of patients were treated with DCB only and 51.0% underwent the hybrid approach combining DCB with DES. Bailout stenting was performed in seven patients (3.5%). The DCB-based PCI group exhibited fewer stents (1.0; IQR: 0.0–1.0 and 2.0; IQR: 1.0–3.0, p < 0.001), shorter stent lengths (6.5 mm; IQR: 0.0–38.0 mm and 42.0 mm; IQR: 28.0–67.0 mm, p < 0.001), and lower usage of small stents with a diameter of 2.5 mm or less (9.8% and 36.5%, p < 0.001). Moreover, the DCB-based PCI group had a lower rate of MACEs than the DES-only PCI group (3.1% and 13.2%, p = 0.001) at 2-year follow-up.
Conclusions
The DCB-based PCI approach significantly reduced the stent burden, particularly in the usage of small stent diameters, and resulted in a lower risk of MACEs compared to DES-only PCI in CTO lesions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, Republic of Korea.
- Division of Cardiology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon 24289, Republic of Korea.
- Department of Cardiology, Korea University Ansan Hospital, Ansan 15355, Republic of Korea.
- Cardiology Department and Clinical Research Center, Queen Elizabeth Hospital II, Kota Kinabalu 88300, Malaysia.
ORCID-Profile: Eun-Seok Shin, Ae-Young Her, Mi Hee Jang, Bitna Kim, Sunwon Kim, Houng Bang Liew
Zitieren
APA
Shin, E. S., Her, A. Y., Jang, M. H., Kim, B., Kim, S., & Liew, H. B. (2024). Impact of Drug-Coated Balloon-Based Revascularization in Patients with Chronic Total Occlusions. Journal of Clinical Medicine, 13(12), 3381. https://doi.org/10.3390/jcm13123381
Vancouver
Shin ES, Her AY, Jang MH, Kim B, Kim S, Liew HB. Impact of Drug-Coated Balloon-Based Revascularization in Patients with Chronic Total Occlusions. Journal of Clinical Medicine. 2024;13(12):3381. doi:10.3390/jcm13123381
BibTeX
@article{Shin2024,
author = {Shin, Eun-Seok and Her, Ae-Young and Jang, Mi Hee and Kim, Bitna and Kim, Sunwon and Liew, Houng Bang},
title = {Impact of Drug-Coated Balloon-Based Revascularization in Patients with Chronic Total Occlusions},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {12},
pages = {3381},
doi = {10.3390/jcm13123381}
}
EUVIMED